A detailed history of Fin Trust Capital Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 2,519 shares of NVO stock, worth $272,077. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,519
Previous 2,224 13.26%
Holding current value
$272,077
Previous $317,000 5.68%
% of portfolio
0.05%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$119.07 - $145.42 $35,125 - $42,898
295 Added 13.26%
2,519 $299,000
Q2 2024

Jul 24, 2024

BUY
$122.71 - $146.91 $10,798 - $12,928
88 Added 4.12%
2,224 $317,000
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $25,425 - $33,844
249 Added 13.2%
2,136 $274,000
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $25,017 - $30,053
285 Added 17.79%
1,887 $195,000
Q3 2023

Oct 24, 2023

BUY
$90.94 - $199.54 $61,839 - $135,687
680 Added 73.75%
1,602 $145,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $2,256 - $2,977
22 Added 2.44%
922 $124,000
Q3 2022

Oct 20, 2022

SELL
$95.28 - $116.93 $24,296 - $29,817
-255 Reduced 22.08%
900 $96,000
Q2 2022

Jul 26, 2022

BUY
$103.24 - $121.81 $45,632 - $53,840
442 Added 61.99%
1,155 $132,000
Q1 2022

May 03, 2022

SELL
$93.1 - $112.54 $1,582 - $1,913
-17 Reduced 2.33%
713 $78,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $10,355 - $12,644
108 Added 17.36%
730 $82,000
Q3 2021

Nov 16, 2021

BUY
$84.42 - $106.62 $844 - $1,066
10 Added 1.63%
622 $60,000
Q2 2021

Aug 16, 2021

SELL
$67.66 - $84.76 $7,713 - $9,662
-114 Reduced 15.7%
612 $51,000
Q1 2021

May 17, 2021

BUY
$67.06 - $75.82 $39,095 - $44,203
583 Added 407.69%
726 $49,000
Q4 2020

Feb 16, 2021

SELL
$63.89 - $73.8 $894 - $1,033
-14 Reduced 8.92%
143 $10,000
Q2 2020

Sep 11, 2020

BUY
$58.54 - $67.94 $9,190 - $10,666
157 New
157 $10,000
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $5,385 - $6,250
-92 Closed
0 $0
Q3 2019

Oct 29, 2019

SELL
$47.54 - $53.43 $2,139 - $2,404
-45 Reduced 32.85%
92 $5,000
Q2 2019

Aug 01, 2019

SELL
$46.79 - $52.47 $12,165 - $13,642
-260 Reduced 65.49%
137 $7,000
Q1 2019

May 09, 2019

BUY
$46.36 - $52.63 $2,596 - $2,947
56 Added 16.42%
397 $21,000
Q4 2018

Feb 11, 2019

BUY
$41.54 - $47.25 $14,165 - $16,112
341 New
341 $16,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.